Modus Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Modus Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 08, 2021	SELL	$181.39 - $202.99 $6,167 - $6,901	-34 Closed	0 $0
Q2 2021 Jul 01, 2021	BUY	$187.49 - $221.1 $6,374 - $7,517	34 New	34 $6,000
Q3 2020 Oct 01, 2020	SELL	$255.65 - $303.1 $8,180 - $9,699	-32 Closed	0 $0
Q2 2020 Jul 01, 2020	BUY	$225.48 - $295.8 $7,215 - $9,465	32 New	32 $9,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Modus Advisors, LLC with notifications on news.